NIH-funded research R01 grant

Acceptance and Commitment Therapy to boost resilience and function after stem cell transplant

Official title: Acceptance and Commitment Therapy to Improve Psychological Resilience and Physical Function in Allogeneic Hematopoietic Stem Cell Transplantation

Funded at University of Kansas Medical Center · NIH-11337293 · Data updated 2026-11-12

A patient-facing program tests whether Acceptance and Commitment Therapy helps people who had an allogeneic stem cell transplant feel better and stay more active.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Kansas Medical Center
NIH-funded
Lab location1 site (Kansas City, United States)
Project startJuly 6, 2026
Project endJune 30, 2031
Funding year2026
Award (this year)$667,933
NIH project number1R01CA311041-01
Project IDNIH-11337293 on NIH RePORTER

Who could benefit from this research

Could help

Adults (21+) who have received an allogeneic hematopoietic stem cell transplant and are navigating treatment-related challenges.

Less likely to help

Some individuals may not respond to ACT or may have barriers to engaging in therapy.

What this research studies

This grant explores using Acceptance and Commitment Therapy (ACT) to help adults who underwent an allogeneic hematopoietic stem cell transplant cope with treatment-related stress, maintain physical activity, and improve daily functioning. The study will adapt a CBT-based ACT approach to address fatigue, discomfort, and distress during cancer treatment, with the goal of increasing psychological flexibility and engagement in valued activities. Researchers at the University of Kansas Medical Center will involve participants in a structured program that combines therapy sessions with practical strategies to stay active and connected to what matters most. Outcomes will focus on quality of life, physical functioning, and symptom interference to guide future care after transplant.

Why it matters

Potential benefit: If successful, patients could experience better mood, more energy, and greater ability to stay active during and after transplant.

How similar studies have gone: Prior ACT-based approaches have shown benefits in reducing distress in various cancer populations, with promising signals in transplant-related settings.

Where this research is happening

  • University of Kansas Medical Center
    Kansas City, United States
    Active

Researchers

  • Principal investigator: Sung, Anthony — University of Kansas Medical Center
  • Study coordinator: Sung, Anthony

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.